Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS), which impacts 1 in 8, or more than 170 million women worldwide.
The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), has just been published in The Lancet and is being announced currently at the European Congress of Endocrinology Conference May 2026.
Here are some resources and videos for you to share with your networks – https://bit.ly/3V85nPJ. There are patient and health professionals resources that have been translated in English, Arabic, Persian, Mandarin, German, Spanish, Portuguese, French, German and other languages.
For more information: https://pcos.together.ualberta.ca/2026/05/12/pcos-has-a-new-name/
